Pfizer PGN 225 (Lyrica 225 mg)

Generic Name: pregabalin

Pill imprint Pfizer PGN 225 has been identified as Lyrica 225 mg.

Lyrica is used in the treatment of neuropathic pain; fibromyalgia; diabetic peripheral neuropathy; neuralgia; postherpetic neuralgia (and more), and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Lyrica 225 mg has a low potential for abuse relative to the drugs in schedule 4. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 4.

See also related documents.

Imprint Search

Images for Pfizer PGN 225

Lyrica 225 mg Pfizer PGN 225
Lyrica 225 mg Pfizer PGN 225
Lyrica
Generic Name:
pregabalin
Imprint:
Pfizer
PGN 225
Strength:
225 mg
Color:
Orange & White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Gamma-aminobutyric acid analogs
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
5 - Some potential for abuse
Manufacturer:
Pfizer U.S. Pharmaceuticals Group
National Drug Code (NDC):
00071-1019
Inactive Ingredients:
lactose monohydrate
corn starch
magnesium silicate
gelatin
titanium dioxide
sodium lauryl sulfate
silicon dioxide
ferric oxide red
shellac
ferrosoferric oxide
propylene glycol
potassium hydroxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
16590-0733 Stat RX USA LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)